Thymidylate synthase (ThS) is a target for antimetabolite antitumor drugs. Such drugs have been
Thymidylate synthase (ThS) is a target for antimetabolite antitumor drugs. Such drugs have been
and quinazolin-4-imine derivatives, well-known
antifolate thymidylate synthase (TYMS)
inhibitors, has been
Ligacheva, A.A.,
Sherstoboev, E.Y.,
Danilets, M.G.,
Trofimova, E.S.,
Krivoshchekov, S.V.,
Gur’ev, A.M.,
Bulgakov, T.V.,
Kudashkina, N.V.,
Miroshnichenko, A.G.,
Belousov, M.V. (2020) macrophage culture induces classical activation of antigen-presenting cells due to an increase in NO
synthaseLigacheva, A.A.,
Sherstoboev, E.Y.,
Danilets, M.G.,
Trofimova, E.S.,
Krivoshchekov, S.V.,
Khasanova, S.R.,
Kudashkina, N.V.,
Gur’ev, A.M.,
Belousov, M.V. (2021) -presenting cells by increasing NO
synthase activity and reducing arginase expression. © 2021, Springer Science
Ivanov, A.M.,
Gil'manov, A.Z.,
Malyutina, N.N.,
Khovaeva, Y.B.,
Nenasheva, O.Y.,
El'kin, G.I.,
Sosnin, D.Y. (2020) . Heterozygote state prevailed for genes of methionine
synthase reductase and folate transport protein among
Fedorova, Yu. Yu.,
Nurgalieva, A.K.,
Petrova, S.G.,
Murzina, R.R.,
Dzhaubermezov, M.A.,
Ekomasova, N.V.,
Khusnutdinova, E.K.,
Prokofieva, D.S. (2024) 1801133 (677C > T), rs1801131 (1298A > C)) and methionine
synthase reductase MTRR (rs1801394 (66A > G